Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The MYCN 5′ UTR as a therapeutic target in neuroblastoma

Cell Reports(2024)10.1016/j.celrep.2024.114134Source: DataRank Database

The MYCN 5′ UTR as a therapeutic target in neuroblastoma is a research paper published in Cell Reports (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

geo gen cellosaurus pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.37)OA: goldTopics (65)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Lauren E. Brown ORCID,Ushashi Banerjee ORCID,Ruben Dries ORCID,Bandana Sharma,Alyssa L. Kennedy ORCID

Live enrichment

PubMed:38662542 PMC:PMC11284644 OpenAlex:https://openalex.org/W4395063652

Alex's Lemonade Stand Foundation for Childhood Cancer

Grant: 21-24757

National Institutes of Health

Grant: R21CA267621

NCATS NIH HHS

Grant: U01 TR002625

National Institutes of Health

Grant: R35GM118173

NCI NIH HHS

Grant: R21 CA267521

National Institutes of Health

Grant: U01TR002625R21

National Institutes of Health

Grant: 3R35GM118173-08S1

Acquisition of a CombiFlash EZ Prep Chromatography System with Integrated ELSD for Chemical Synthesis

FWCI

1.37

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2211124724004625/pdf

publisherhttp://www.cell.com/article/S2211124724004625/pdf

journalhttps://doi.org/10.1016/j.celrep.2024.114134

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38662542

repositoryhttps://www.ncbi.nlm.nih.gov/pubmed/38662542

Fields of Study

Neuroblastoma Research and TreatmentsVirus-based gene therapy researchProtein Degradation and Inhibitors0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

N-Myc Proto-Oncogene ProteinAnimalsFemaleHumansMice, Inbred C57BLNeuroblastomaRNA, Messenger5' Untranslated RegionsEukaryotic Initiation Factor-4ACell Line, TumorCell ProliferationMice

Keywords

NeuroblastomaEIF4A1RNA Helicase AUntranslated regionBiologyThree prime untranslated regionCancer researchCell biologyTranslation (biology)GeneticsHelicaseMessenger RNARNAGeneCell cultureTranslationTranslation RegulationMycnRibosome ProfilingMycn AmplificationPar-clipRocaglateCp: Molecular BiologyCp: CancerAmidino-rocaglatetumor570QH301-705.55' Untranslated regions610N-Myc proto-oncogene proteinArticleMiceMedical physiologyCell Line, TumorAnimalsHumansRNA, MessengerBiology (General)Cell proliferationmessengerMice, Inbred C57BLBiological sciencesBiochemistry and cell biologyEukaryotic Initiation Factor-4AFemaleCell line

Sustainable Development Goals

SDG 0: Good health and well-being

The MYCN 5′ UTR as a therapeutic target in neuroblastoma

FAIR Checklist

Authors (8)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)